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INTRODUCTION 
 Cervical Cancer remains worldwide the second most common cancer 
among women accounting for 15% of all female cancers.  It is the most common 
cancer among women in many developing countries constituting 20-30% of 
female cancers.  In developed western countries it accounts for only 4 - 6% of 
female cancers.  This difference largely reflects the impact of mass screening 
using cervical cytologic methods. 
 The purpose of cytologic screening is to identify those women who have a 
intraepithelial lesion (CIN) and not those who have cancer.  If disease can be 
detected & treated at this preinvasive stage outcome should significantly improve. 
 For a screening system to be effective it must fulfill six basic requirements. 
a) The test must detect the disease in a stage where early treatment will 
provide a Superior prognosis to treatment in a later stage. 
b) The test must be sufficiently sensitive to detect the disease in an early 
stage. 
c)  The test must be sufficiently specific to distinguish non specific 
changes from the disease. 
d) The test must be cost effective. 
e) The test must be sufficiently simple to administer. 
f) The screening procedure must be acceptable to those undergoing 
screening. 
Cervical Cytology Meets All Of These Requirements 
And also in all probability cervical cancer is the only gynecological 
malignancy that satisfies the well recognized WHO criteria for implementation of 
a screening program. 
¾ Existence of well defined premalignant lesions 
¾ Long Latent period in which premalignant change or occult cancers can be 
detected and effectively treated thereby altering the natural history of the 
disease. 
¾ A clearly defined viral etiology, which could be incorporated as a marker in 
mass screening program. 
¾ Easy & direct access of the uterine cervix for examination and sampling. 
¾ Effective treatments available for the premaligant changes. 
 In the last 40 years developed countries like United States & British 
Columbia have shown a decrease in the incidence & mortality of invasive cancer 
cervix by effective cancer screening programmes. (Coleman et al) 
 But the scenario has not changed in the developing countries due to 
socioeconomic, cultural or political conditions.   So the need to educate women & 
their health care providers about the importance of screening is evident. 
 AIM OF THE STUDY 
 1. To compare the cytologic diagnosis, specimen adequacy, sensitivity, 
cost effectiveness of Liquid based cytology with that of conventional 
pap test. 
 2. To correlate diagnostic colposcopy with histopathology in patients 
with abnormal cytology reports. 
 3. To study the accuracy of combined screening procedures. 
REVIEW OF LITERATURE 
 The uterine cervix is the most common site of cancer in most developing 
countries including India.  The age adjusted incidence of cancer of uterine cervix 
is 18.9/1,00,000 in Chennai. It is the 2nd most common cancer in female next to 
breast cancer in Chennai. (population based cancer registry, ICMR, Adyar, 
Chennai 2003). 
Origin 
 The endocervical canal is lined by columnar epithelium and the portio 
vaginalis is lined by squamous epithelium and the place they meet is the squamo 
columnar junction.  Normally there is not an abrupt transformation from columnar 
to squamous epithelium. A transitional area called “transformation zone” which 
consists of highly active young metaplastic cell is present.   The transformation 
zone is highly active prior to birth, at menarche, during & after first pregnancy.  
The process of eversion exposes the columnar epithelium to the low vaginal PH 
which is the main trigger for metaplastic activity & the vaginal PH is under the 
influence of estrogen.  The young metaplastic cells possess the property of 
phagocytosis.  Early sexual activity which when occurs during this high 
metaplastic activity provides mutagens like sperms, virus and foreign bodies.  The 
nucleicacids  of sperms and virus may get incorporated in the cells during the 
process of active mitosis & get transformed to abnormal cells. 
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Natural History 
 Squamous cell carcinoma of the cervix fulfills the model for a classic 
multistage disease beginning with the acquisition of a precursor lesion, 
morphologic progression of the precursor during the course of time, and in some 
cases, the development of invasive carcinoma.  The fact that this process takes as 
much as 20 years to evolve has been the basis for cytologic screening for detection 
of preinvasive disease. 
DUNN described the yawning gap phenomenon in 1968 of cancer cervix. 
 
 
 
 
 
 
 
 The graph shows substantial gap between cumulative incidence of insitu 
carcinoma and that of invasive carcinoma even when added to the later the 
prevalence of preclinical carcinoma. 
 Barron &  Richart estimated that 66% would progress from cytological 
dysplasia to carcinoma insitu over a 10 year follow up. 
 Barron et al estimated that the duration of carcinoma insitu ranged from  
3-10 years. 
   
                Persistence   
            (> 1 year) 
 
 
 
HPV 
Normal  Infection infected Progression      Pre-    Invasion 
Cervix    Cervix   cancer  
Clearance   Regression   Cancer 
   
 
 
       Mild Cytologic  
  Abnormalities and/or Seroconversion 
 
 
 
Natural History of CIN - Literature review - Ostor (1993) 
 
 Patients Regress Persist Progress to
CIN 3 
Progress to 
invasive 
cancer 
CIN 1 4,504 57% 32% 11% 1% 
CIN 2 2,247 43% 35% 22% 5% 
CIN 3 767 32% >56% - >12% 
 
Epidemiology  
 The average age of patients with carcinoma insitu reproducibly is 10-15 
years less than the average age of patients with invasive cancer of the cervix.  
Numerous studies of epidemiology of cervical cancer have shown strong 
associations with several risk factors.  
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 Historical Background of terminology 
 The proposal that invasive squamous carcinoma of the cervix arises through 
progression of a preinvasive lesion as apposed to a de novo event was initially 
postulated by SCHAUENSTEIN in 1908. 
 The term carcinoma in situ (CIS) was later introduced to describe cancerous 
changes confined to the epithelium. 
 The concept of cervical intrapitnelial neoplasia (CIN) was introduced by 
Richart 1967. 
 CIN is a histological term used to describe a full thickness epithelial 
change. 
CIN is divided for convenience utility into three categories  CIN 1,2,3. 
Dyskaryosis literally mean ‘Bad Kernel’ and identified by changes in the 
nuclear pattern. According to Bethesda classification,   
Nuclear abnormality in mature cells represent LSIL 
Nuclear abnormality in immature cells represent HSIL. 
 
 Reagen & Hamonic in 1956 described cytologic differences between 
carcinoma Insitu and a group of less anaplastic lesions for which they introduced 
the term dysplasia. 
 If only the basal one third of epithelium characterized by cytologic atypia, 
increased mitotic activity and loss of polarity - they were referred to as mild 
dysplasia. If changes extending into the middle third - moderate dysplasia and 
more than 2/3rd of epithelium involved severe dysplasia. International congress on 
exfoliative cytology in 1961 accepted the following definition. 
 The original cytologic classification (Class System) of papanicolaou was 
replaced gradually by histologic terms of mild, moderate, severe dysplasia and 
carcinoma in situ and then came the Bethesda system in 1989 which combined 
HPV cytopathologic effects, often referred to as koilocytosis with mild dysplasia 
or CIN I to LSIL (Low grade squamous intraepithelial lesion) and moderate, 
severe, CIS ad HSIL (High grade squamous intraepithelial lesion) and today the 
Bethesda 2001 classification have been widely used.  
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 In 1975 WHO defined dysplasia as a lesion in which part of the epithelium 
is replaced by cells showing varying degrees of atypia. 
 Richart grades them according to number of  parabasal cells. 
 Less than 10% Parabasal cells - mild dysplasia 
 10 – 20%    - moderate dysplasia 
 >30%     - severe dysplasia 
 Reagen grades them according to nuclear size  
      Average nucleus size 
study of  2500 normal cells  -  7 microns 
study of 5000 dysplastic cells - 14 microns 
study of 6500 CIS cells  - 13 microns 
 
SCREENING FOR CERVICAL NEOPLASIA 
 In 1928 Dr. George N. Papanicolaou, an anatomist reported that 
malignant cells from the cervix could be identified in vaginal smears in his report 
on “new cancer diagnosis”. 
 A Canadian gynaecologist Dr. J. Ernest Ayre 1947 suggested taking 
samples directly from the cervix with a wooden spatula rather than from the 
vagina with a pipette as Originally described by papanicolaou. 
 The first screening clinics were established in 1940’s.   
Recommended screening interval vary among different countries. 
When to start 
 The American Cancer Society recommends that all women who are or have 
been sexually active or are 18 yrs. of age or older whichever is earlier have an 
annual pap test and pelvic examination. 
Canadian Task Force 1982 also suggests this. 
What should the pap smear interval be 
 Ideally pap smear has to be repeated annually.  But this may not be cost 
effective.  The Canadian Task Force 1982 suggested that a pap smear at 3 yrs. 
interval would be adequate upto the age of 55 yrs.  Thereafter the chances of 
developing cancer cervix is remote. 
 WHO advices that each women must undergo a cytology screening at least 
once in her life time.  Case control studies on cervical cancer screening found a 
relative fall in incidence of 2.7% in Canada by Clark and Anderson and 3.2% in 
Switzerland (Raymond et al 1984) after one or more negative smears. 
 It may be worthwhile to keep the following recommendations of the United 
States preventive services task force (US PSTF) in mind while considering the 
above mentioned issues. 
¾ All women who are sexually active should be offered screening. 
¾ Screening should begin at 21 years of 3 years within starting sexual 
activity, whichever is earlier. 
¾ Screening is recommended every 3 years. 
¾ Screening is not recommended in women > 65 yrs provided they have been 
regularly screened before and are not at a high risk for cervical cancer. 
¾ Current evidence is insufficient to recommend for or against the use of  
routine HPV testing for screening for cervical cancer. 
Screening should take place at least every 3 years.  Despite these globally 
positive results, errors do occur in using the pap smear. 
What is the appropriate age to stop screening 
 The appropriate age to stop screening is still undefined but as more women 
enter properly structured programmes it is more likely that the age for 
discontinuation will fall rather than rise. 
Efficacy of pap smear  
 Eventhough pap screening is most simple and economical method it is not 
100% accurate and it is credited with 87% accuracy. 
 It has a certain false positive and false negative rate. 
 A single pap smear has a sensitivity of only 50-60% , this means that a 
single test will not detect a cervical lesion in many women.  However even with 
this limited sensitivity if three consecutive tests are negative there is less than a 
1% chance that the patient will have a cervical abnormality. 
 It has also been admitted that the method was ardous and time consuming 
in the microscopic search for the specifically malignant cells sometimes obscured 
by the cellular desquamate, leucocytes and blood.  Since then efforts have been 
made to improve the technique, simplify the methods and extend its application. 
A meta analysis consigning data from 59 studies compared pap with 
histology and concluded that pap is unable to achieve high sensitivity and high 
specificity concurrently. (Fahey et al 1995)  
False Positive   
Reasons  
Atypical cells especially those shed from hyperplastic and metaplastic 
cervical lesions, acute inflamnation often assoicated with hypoestrogenesim 
resembles carcinomatous cells.    
 
False Negative  
Reasons  
 Improper cell collections 
 Absence of endocervical cells 
 Smears too thick 
 Bloody smears 
 Improper fixation 
 Incorrect staining 
Liquid based Cytology  
 The introduction of cyto centrifuge in 1966 was a great step forward in 
LBC (Watson 1966) and it is a new way of preparing cervical samples for 
examination in the laboratory. 
 To decrease the false negative rate of cervical cytology over the past 
several years several liquid based techniques have been developed.  These 
techniques differ from the conventional method of pap smear collection in several 
ways.   
 Once the scrapings are taken from the SCJ and transformation zone area the 
brush is rinsed directly into the vial containing preservative fluid, rather than being 
smeared on a glass slide.  The vial is labelled and sent to the cytology laboratory.   
Once in the lab, the sample fluid is spun and treated to remove obscuring 
material for example mucus or pus and a random sample of  the remaining cells is 
taken.  The slide is then stained with the conventional papanicolaou stain and slide 
read under microscope. 
 Several studies have shown that more diagnostic cervical cells are collected 
by this liquid based technique and provide a cleaner appearance with less 
clumping, blood and inflammatory changes thus providing a better specimen and 
hopefully a better interpretation. 
 
 
 
 
 
 
 
 
LBC reduces the rate of false -ve results from both screening and 
interpretation errors. 
 LBC has reduced the pressure on a skilled work force reduced money 
overall, reduced levels of anxiety in women, a quicker reporting time. 
 The evaluation of pilot studies and NICE recognises that LBC is as good as 
conventional smear test and it is cost effective. 
Specimen Adequacy  
 One of the most important advances of the Bethesda system is its 
recommendation that each pap report should begin with a statement of adequacy.  
The 2001 Bethesda system has categorised the specimen adequacy as follows :- 
Satisfactory for evaluation  indicates the presence of 
¾ A satisfactory squamous component.  
¾ Adequate endocervical / transformation  zone component. 
¾ Obscuring elements (inflammation, blood, drying artifact, other) 
may be mentioned if 50-75% of epithelial cells are obscured. 
¾ Relevant clinical information 
¾ Appropriate labelling and indentifying information 
Satisfactory for evaluation but limited by 
¾ Lack of patient clinical information 
¾ Partially obscuring blood, inflammation with precludes 
interpretation of approximately 50-75% of the epithelial cells. 
 
Unsatisfactory for evaluation  
Specimen rejected/not processed Reasons may include : 
¾ Lack of patient identification 
¾ Unacceptable  specimen (eg. Slide broken beyond repair) 
¾ Insufficient squamous component  
¾ Obscuring elements cover more than 75% of epithelial cells. 
 
One of the components of adequate smear is an adequate squamous 
component.  According to Betnesda the requirement for an adequate squamous 
component was defined as well preserved and well visualized.  Squamous 
epithelial cells should cover more than 10% of slide surface. The estimated 
minimum number of squamous cells for  
 Liquid based cytology – 5000 
 Conventional pap – 8000- 12,000 
 Because liquid based preparations likely represent a more homogeneous 
representation of the material obtained by the collection device a more stringent 
requirement was imposed on conventional smears. 
 A smear without endocervical cells is not considered unsatisfactory, 
although the absence of an endocervical  / transformation Zone component is 
mentioned as a quality indicator. 
New Diagnostic Screening Tests 
Automated Screening Technology 
 
 The following technics that rely largely on neural network technology and 
are based on the computerized imaging and identification of abnormal cervical 
cells are available. 
¾ Auto pap 300 (Tripath imaging, Burlington NC) 
¾ PAPNET (Neuromedical systems). 
Colposcope 
 Colposcopy is the examination of vagina and cervix with a binocular 
microscope. The word "Colposcope" is derived from the greek word kolpos (fold 
or hollow) and skope (examine). 
 The first colposcope was developed by Hans Hinselmann of Hamburg, 
Germany in 1925. Colposcopy has become an integral part of modern 
Gynecologic practice. It is extensively used for the evaluation of epithelium of 
cervix although the other indications for colposcope has increased.  
Colposcopy is best performed in concert with cytology. 
Colposcopic examination 
 The are two methods of examination. 
 1. The saline method 
 2. The classical or extended method. 
 The classical or extended method is widely used. 
Indications for colposcope 
 1. Abnormal pap smears 
 2. Colposcope directed Biopsy in patients with abnormal pap smear. 
 3. VIA positive sites for biopsy 
 4. Suspicious cervix 
Grading 
 The grading system devised by coppleson and co-workers is extensively 
used in modern colposcopy. 
Grade I (insignificant, not suspicious) 
 Acetowhite epithelium, borders not necessarily sharp, absence of atypical 
vessels. 
 The predicted histology is CINI (LSIL), metaplastic epithelium (mature and 
immature). 
Grade II (Significant, Suspicious) 
 Acetowhite epithelium with sharp borders, regularly shaped vessels, 
absence of atypical vessels. 
 The predicted histology is CIN 2- 3 (HSIL) 
Grade III (Highly significant, highly suspicious) 
 White or grey opaque epithelium, sharply bordered; irregularly shaped 
atypical vessels predicted histology CIN 3 (HSIL) or early invasive cancer. 
Benefits of Colposcope 
• This can be done on outpatient basis. 
• A directed biopsy for definitive histological diagnosis could be 
performed if required, then and there. 
• If required the pre-cancer lesion could be treated with cryotherapy 
immediately. 
• The future management could be planned without delay. 
Basis of Colposcopic Appearances 
 International Federation of Cervical Pathology and coloposcopy May 1990, 
Italy). 
 A. Normal Colposcopical findings: 
• Original Squamous Epithelium 
• Original Columnar epithelium 
• Transformation Zone (Metaplastic epthelium) 
B. Abnormal Colposcopic findings:5 
 Within the transformation zone 
  1. Acetowhite Epithelium 
  2. Leukoplakia (thin or Thick) 
  3. Mosaics (fine or coarse) 
  4. Punctation (fine or coarse) 
  5. Atypical vessels 
Histopathological Examination 
 Histopathological examination is generally regarded as the gold standard in 
the diagnosis of cervical carcinoma so that the conventional teaching is that a 
positive cytology must be confirmed by Biopsy. However reports of false 
positive and false negative do exist. Studying concordance and discordance 
between histopathology, cytology and colposcopic diagnosis of colposcopically 
directed biopsy make screening easier and more sensitive. 
Correlation between cytology report and Histopathology report 
Advantages 
 Cytopathological methods provide a rapid, inexpensive simple means of 
diagnosis. 
 1. No injury to tissue is produced 
2. Psychological advantages, better accepted by the patient and the 
physician because it is often  considered to be a routine test. 
3. Covers a wider surface than that involved in a biopsy. 
4. Cells can be obtained from areas inaccessible to a biopsy. 
5. Smears permit a better evaluation of the nature of inflammation or 
infections. 
Limitations 
1. The cytologic diagnosis is not always final, it must be confirmed by 
histology. 
 
MATERIAL AND METHOD 
Selection of Cases 
A random selection of 300 patients attending  as outpatient  in 
gynaecological department at government Kilpauk Hospital, chennai during the 
year 2005- 2006 . 
Inclusion Criteria  
Women who are sexually active, including post menopausal women. No 
previous screening test taken . 
Exclusion Criteria 
Antenatal and  Postnatal mothers, previous screening test taken, proven 
preinvasive lesions and on treatment, menstruating women. 
Method 
A detailed history of the patient taken and the patient informed about the 
screening procedures and counselling given regarding the necessity for their 
participation in screening program. 
Their awareness regarding the screening Programs and tests offered were 
assessed. Both conventional pap and liquid based cytology were performed in the 
same patient. 
 
Pap smear  
Materials 
 
 Cusco's bivalved self retaining speculum 
 Nulliparous   - 28mm 
 Postmenopause - 28mm 
 Multiparous  - 36mm 
 Light source 
 Ayre's Spatula 
 Glass slide 
 Marker pencil 
 Sterile glove 
 Cytofix spray 
Method 
 Patient was put in lithotomy position and a suitable size cusco's speculum 
was introduced without lubricant. Cervical smear taken with Ayre's spaula rotating 
it through 360° over the squamocolumnar junction. 
 The smear was evenly spread over the glass slide marked with the pap 
smear number for that patient and immediately spray fixed. 
 
Liquid based cytology 
Materials 
 Cusco's bivalved self retaining speculum 
 Light source 
 Cervical brush 
 Vial with 6ml of methanol based preservative solution 
 Sterile glove 
 After conventional pap taken the cervical brush is inserted into cervical 
canal, some bristles should still be visible. If inserted too far there may be 
inadvertent sampling of the lower uterine segment (LUS) which causes diagnostic 
difficulties because its epithelium resembles HSIL, and adenocarcinoma insitu 
(AIS). Brush is used to take both ecto / endocervical sampling. Brush is rotated in 
the canal 180 degrees to limit bleeding and to increase specimen adequacy.  
A full rotation is unnecessary because the circumferential bristles are in 
contact with the entire surface the moment the brush is inserted. 
 The brush is immediately rinsed in to 6 ml of vial containing preservative 
fluid and capped.     
The slide and the vial are labelled and sent to the laboratory.  The 
conventional smear containing slide is stained directly by the papanicolaou 
staining method.  
Lab processing 
 The vial sample is now transferred to the cell funnel (reusable) and funnel 
is attached to a single circle slide with a filter card in between. The filter  card will 
have a small hole for collection of cells on to the slide. The circle on the slide and 
filter card hole should be at the same side. The cell funnel, filter card and slide are 
attached together in a cell clip and placed in a aerosol tight sealed cell spin rotor 
which is designed for upto 12 samples x 6 cc per run. This cell spin rotor is placed 
in cytospin.  
 Cytospin is a cytocentrifuge which concentrates only cells in the liquid 
sample on to the slide. The supernatant fluid containing no cells and obscuring 
material like blood and mucus is absorbed by the filter card. The cytopsin is 
operated and cell spin rotor is subjected to 3,000 rpm for 10 minutes the slide with 
the resulting cell sample is now taken from the cell clip and stained by routine 
papanicolaou stain. Patients who were found to be with abnormal cytology 
reportes were subjected to colposcopy directed biopsy. 
Cell Staining  
 Consistency and reliability in staining are the corner stones of cytological 
interpretation.  The universal stain for cytological preparation is papanicolaou 
stain.   
 Harris haematoxylin is the optimum nuclear stain and the combination of 
0G6 and EA 50 give the subtle range of green, blue and pink hues to the cell 
cytoplasm. 
 
Staining Method  
 The slides are stained by the following procedure  
1. Remove polyethylene glycol fixative in 50% alcohol 2 min. This 
step is important in preparation of spray fixed sample that is to 
remove carbowax. Without this important step the dye will not be 
able to penetrate the cells, resulting in cloudy or hazy appearance, 
especially of nuclear chromatin pattern. 
2. Hydrate in 95% alcohol 2 min and 70% alcohol 2 min 
3. Rinse in water 1 min. 
4. Stain in Harri’s Haemotoxylin 5 min. 
5. Rinse in water 2 min. 
6. Differentiate in 0.5% aqueous hydrochloric acid 10 seconds approx. 
7. Rinse in water, 2 min. 
8. 0.1% of ammoniated water, 2 min. 
9. Rinse in water, 2 min. 
10. Dehydrate, 70% alcohol for 2 min. 
11. Dehydrate, 95% alcohol for 2 min. 
12. Dehydrate, 95% alcohol for 2 min. 
13. Stain in 096, 2 min. 
14. Rinse in 95% alcohol, 2 min. 
15. Rinse in 95% alcohol, 2 min. 
16. Stain in EA 50, 3 min. 
17. Rinse in 95% alcohol, 1 min. 
Slides are mounted on with DPX. 
  
Microscopic appearance  
 Nucleus     - Blue colour 
 
 Cytoplasm of superficial Cells - Pink 
 
Intermediate cell   - Bluish Green 
 
Cytoplasm (non –keratinizing  
squamous cells)   - blue / green 
 
Keratinizing cells   - pink / orange 
 
 
Abnormalites noted  
 Disproportionate nuclear enlargement 
 Variation in size and shape of nuclei 
 Irregularity of nuclei outline 
 Hyper chromasia and clumping of nuclear chromatin 
 Abnormal no. of size or form of nucleoli 
 Multi nucleation associated with any of the above. 
 Perinuclear halo. 
Colposcopy 
Materials 
 Colposcope 
 Bivalved cusco speculum 
 Cotton tipped swabs 
 Sterile glove 
 Normal saline 
 3% Acetic acid 
 Lugol's Iodine 
 Examination table with height adjustment. 
 
 The magnification is 13.5 times. 
With the patients in lithotomy position colposcope was positioned and the 
objective lens adjusted to bring the cervix into focus. 
The cervix and  vagina are cleaned with cotton swab with normal saline 
cervix was inspected for lesions leucoplakia, carcinoma, viral condylomata. Then 
a solution of 3% acetic acid was liberally applied over the cervix. The solution is 
mucolytic and changes the colour and vascular pattern after an internal of 10 - 30 
seconds. 
The cervix was inspected for colour, surface, columnar epithelium, 
transformation zone, SCJ and vascular pattern. The vascular pattern was again 
studied using a green filter schiller's Iodine test was done for patients with 
suspicious lesions. 
The special symbols for the different colposcopical patterns are used by the 
colposcopist to document the colposcopic finding which imitate as closely as 
possible the picture observe in the colposcope. 
The 2 recording systems in vogue are 
1. Odell diagram colposcopic lesions may be represented in a circular 
diagram in relation to the os. 
2. Modified Hammond's graph of cervix. 
It consists of 3 concentric circles with 12 radial lesions in clockwise 
fashion. The inner most represent endocervix, intermediate one is the 
transformation zone and the outermost is the ectocervix.. 
Biopsy cervix 
Materials  
Sterile glove 
 Vulsellum 
 Light source 
 Tischler biopsy forceps 
 Container with 10% formalin 
 
The biopsy material was fixed in 10% formalin immediately. The fixed 
material was then imbedded in wax for section cutting. The sections were then 
subjected to Haemotoxylin and eosin staining for reading the changes in the 
squamous lining in respect of inflammation, ulceration, dysplasia, CIS, micro 
invasive carcinoma and invasive carcinoma.  
The management of abnormal lesion is finally dependent upon the 
histopathological diagnosis. Biopsies were taken from Iodine negative areas or 
areas of atypical colposcopic findings. all biopsies were done under colposcopic 
guidance. 
 
RESULT AND ANALYSIS 
TABLE - 1 
AGE DISTRIBUTION OF THE PATIENTS WHO WERE 
SCREENED WITH CYTOLOGY 
Age in decades Number of cases Percentage 
20-30 78 26 
31-40 151 50.3 
41-50 65 21.7 
51-60 6 2 
Total 300 100 
 
 Mean ± S.D = 35.73667 ± 7.219491 
 The number of cases screened were more in the age group of 31 - 40 - 
50.3%.  
TABLE - 2 
PARITY DISTRIBUTION 
Parity Number of cases Percentage 
0-2 117 39 
3-5 180 60 
>5 3 1 
  Total 300 100 
 
 61% of the cases screened were multipara >  3 
  
TABLE - 3 
 
EDUCATIONAL STATUS 
 
Education Number of cases Percentage 
Illiterate 114 38 
Primary 68 22.7 
Secondary & Above 118 39.3 
Total 300 100 
 
  
TABLE - 4 
 
SOCIOECONOMIC STATUS 
 
Class Number of cases Percentage 
I - - 
II - - 
III 45 15 
IV 120 40 
V 135 45 
Total 300 100 
 
TABLE - 5 
 
MENSTRUAL STATUS 
 
 
 No.of cases Percentage 
Menstruating 291 97 
Post menopausal 9 3 
Total 300 100 
 
TABLE - 6 
 Mean ± SD 
Age at 1st coitus 18.87 ± 2.47476 
Age at Marriage 18.93 ± 2.501859 
Duration of Marriage 16.20 ± 7.831671 
LCB 8.11 ± 4.779877 
 
 This table shows early age of marriage and 1st coitus among the study 
group. 
TABLE - 7 
 
CONTRACEPTION 
 
 Number of cases Percentage 
Barrier (condom) 3 1 
IUCD 9 3 
OCP 6 2 
Female sterilization 144 48 
Male sterilization - - 
No method followed 138 46 
Total 300 100 
 
 99% of cases in this study has constant sperm exposure. Only 1% followed 
barrier contraception. 
TABLE - 8 
 
ABORTION STATUS 
 
 Number of cases Percentage 
MTP with 
sterilization 
27 9 
Spontaneous 
abortion 
51 17 
MTP 12 4 
No H/o Abortion 210 70 
Total 300 100 
 
 9% of the cases screened had unwanted pregnancy and went for MTP with 
sterilization. 
 TABLE - 9 
 
EXTRA / PREMARITAL CONTACT OF WOMEN 
 
 Number of cases Percentage 
Yes 8 2.7 
No 292 97.3 
Total 300 100 
 
 
TABLE - 10 
 
EXTRA / PREMARITAL CONTACT OF HUSBAND 
 
 Number of cases Percentage 
Yes 32 10.7 
No 268 89.3 
Total 300 100 
 
 TABLE - 11 
 
TREATED FOR STD 
 
 Number of couples Percentage 
Yes 48 16 
No 252 84 
Total 300 100 
 
 
 16% of cases screened have taken treatment for STD including partner 
treatment. 
TABLE - 12 
CERVICAL CHANGES IN WOMEN TREATED FOR STD 
Treated for STD (n=48)  
LBC No.of cases Percentage 
Normal 35 72.9 
Cervical changes 13 27.1 
Total 48 100 
 
 Out of 48 couples treated for STD 13 women had cervical changes. This 
shows the impact of sexually transmitted disease in the etiology of cancer cervix. 
TABLE - 13 
 
PRESENTING COMPLAINT 
 
Complaints Number of cases Percentage 
White discharge 173 57.7 
UTI 34 11.3 
Lower Abdominal pain 34 11.3 
Low Back Ache 30 10 
Inferility 4 1.3 
Mass P/V 11 3.7 
Mass P/A 4 1.3 
Dysmenorrhea 10 3.4 
Total 300 100 
 
 
 57.7% of cases screened has their main complaint as white discharge PV. 
The next common complaint was urinary tract infection and Lower abdominal 
pain. 
TABLE - 14 
CERVICAL STATUS 
 
 Number of cases Percentage 
Normal 100 33.3 
Erosion 140 46.7 
Hypertrophy 35 11.7 
Old cervical tear 25 8.3 
Total 300 100 
 
 
 46.7% of cases screened had cervical erosion and 33.3% had normal cervix 
with speculum examination. 
TABLE - 15 
 
LOCAL EXAMINATION 
 
 Number of cases Percentage 
Normal 211 70.4 
Discharge 56 18.6 
UV prolapse 9 3 
Excoriation 12 4 
Wart 7 2.3 
Others 5 1.7 
Total 300 100 
 
 
 
About 70.4% cases screened were normal in local examination. 18.6% of 
cases had discharge. 
 
TABLE - 16 
 
INFECTIONS 
 
 Number of cases Percentage 
Normal 240 80 
Trichomonas 40 13.3 
Candida 20 6.7 
Total 300 100 
 
 
 13.3% of cases screened had Trichomonas infection and 6.7% of cases 
screened had candidal infection. Out of 6.7% cases 2% cases were known diabetic 
and on treatment. 
TABLE - 17 
 
CYTOLOGIC DIAGNOSIS 
 
Pap LBC Cytology 
n % n % 
Normal 64 21.3 232 77.3 
Inflammatory smear 200 66.7 16 5.3 
Mild dysplasia 30 10 32 10.7 
Moderate dysplasia 3 1 3 1 
Severe dysplasia 2 0.7 11 3.7 
Cancer 1 0.3 6 2 
Total 300 100 300 100 
 
 LBC - LSIL - 10.7%,  HSIL - 4.7%,   Cancer - 2% 
 PAP - LSIL - 10%,  HSIL - 1.7%,  Cancer - 0.3% 
 
TABLE - 18 
 
COST ESTIMATION PER WOMAN  
 
Materials Pap 
(Rs.) 
LBC 
(Rs.) 
Ayre's Spatula 6 - 
Brush - 12 
Slide 1 1 
Cytofix spray 3.50 - 
Vial with preservative fluid - 16 
Lab processing 23 40 
Total 33.50 69 
TABLE - 19 
 
COMPARISON OF SPECIMEN ADEQUACY OF LBC  
WITH THAT OF CONVENTIONAL PAP 
 
PAP LBC   
n % n % 
1. Satisfactory 170 56.7 290 96.7 
2. Satisfactory for evaluation 
but limited by 
    
 (a) Air drying artifact 39 13 1 0.3 
 (b) Thick smear 37 12.3 4 1.3 
 (c) Endocervical  
 component absent 
14 4.7 2 0.7 
 (d) Scant squamous 
  epithelial component 
12 3.3 2. 0.7 
 (e) Obscuring blood 24 8 1 0.3 
 (f) No clinical history - - - - 
 (g) Cytolysis 2 0.7 - - 
 (h) Others 2 0.7 - - 
3. Unsatisfactory for 
evaluation 
    
 (a) Air drying artifact - - - - 
 (b) Thick smear - - - - 
 (c) Endocervical  
 component absent 
- - - - 
 (d) Scant squamous 
  epithelial component 
- - - - 
 (e) Obscuring blood - - - - 
 (f) No clinical history - - - - 
 (g) Cytolysis - - - - 
 (h) Others - - - - 
 
* A slide may have more than one factor.
TABLE - 20 
 
SENSITIVITY / SPECIFICITY OF PAP 
 
LBC 
Pap Cancer cervix Normal Total 
Cancer cervix 20 
                     (a) 
16 
                        (b)
36 
Normal 32 
                     (c) 
232 
                        (d)
264 
Total 52 248 300 
 
Sensitivity (a/a+c)   =  20/52 = 0.38 
(true positive) 
            38% 
Specificity (d/b+d)   =  232/248 = 0.93 
(true negative) 
            93% 
 Positive predictive value  (a/a+b) = 20/36 = 0.55 
           55% 
 Negative predictive value  (d/c+d) = 232/264 = 0.87 
           87%  
 Percentage of false positive (b/b+d) = 16/232 = 0.069 
       6.9% 
 Percentage of false negative (c/a+c) = 32/52 = 0.61 
       61.6% 
TABLE - 21 
 
 
CERVICAL CHANGES DETECTED BY LBC  
WITH THAT OF HISTOLOGY 
 
HISTOLOGY 
LBC Cervicitis MD MOD SD Ca Total 
MD 12 19 1 - - 32 
MOD - 1 1 1 - 3 
SD - - 2 8 1 11 
Ca - - - - 6 6 
Total 12 20 4 9 7 52 
 
  
 Low grade squamous intraepithelial neoplasia (Mild dysplasia) - out of 32 
cases 20 cases had cervical changes. 
 
 LSIL detection rate of LBC in this study is 63%. 
 
 High grade squamous intraepithelial neoplasia (Moderate and severe 
dysplasia) out of 14 HSIL 1 case was diagnosed as invasive cancer and 1 case as 
LSIL 
 
 HSIL detection rate 85%. 
TABLE - 22 
 
COMPARATIVE ANALYSIS WITH VARIOUS STUDIES 
 
Sensitivity% Specificity % Authors 
LBC Pap LBC Pap 
Sulik et al (2001) 70 79 85 89 
Bergeron (2001) 66 61 9.6 11 
Park (2001) 45 49 27 23 
Bishop (1998) 89 78 44 17 
Bolick (1998) 95 85 58 36 
Ferris (2000) 52 63 99 99 
Brown & Garber (1999) 93 82 96 96 
Maxwell (2003) 67 60 97 97 
Nice (2003) 67 60 97 97 
Present study 97 38 56 93 
 
TABLE - 23 
 
 
VAGINAL CYTOLOGY REPORTS AT KMCH  
FOR THE PAST 3 YEARS  
 
Present study 2003 
(Pap) 
2004 
(Pap) 
2005 
(Pap) Pap LBC 
 
Year 
n % n % n % n % n % 
Total slides 709 - 1540 - 890 - 300 - 300 - 
Non Specific 252 36 476 31 285 32 64 21 232 77.3 
Inflammatory 397 56 890 58 515 58 200 67 16 5.3 
Atypical 60 8 174 11 90 10 36 12 52 17.4 
TABLE - 24 
SENSITIVITY / SPECIFICITY OF LBC 
 
Histology 
LBC Cervical changes Normal Total 
Cervical changes 40 
                     (a) 
12 
                        (b)
52 
Normal 1 
                     (c) 
15 
                        (d)
16 
Total 41 27 68 
 
Sensitivity (a/a+c)   =  40/41 = 0.97 
(true positive) 
           97% 
Specificity (d/b+d)   =  15/27 = 0.56 
(true negative) 
            56% 
 Positive predictive value  (a/a+b) = 40/52 = 0.77 
           77% 
 Negative predictive value  (d/c+d) = 15/16 = 0.94 
           94%  
 Percentage of false positive b/b+d = 12/27 = 0.44 
           44%  
 Percentage of false negative c/a+c = 1/41 = 0.02 
           2% 
TABLE - 25 
SENSITIVITY / SPECIFICITY OF COLPOSCOPE 
 
Histology 
Colpo Cervical changes Normal Total 
Cervical changes 33 
                     (a) 
8 
                        (b)
41 
Normal 8 
                     (c) 
19 
                        (d)
27 
Total 41 27 68 
 
Sensitivity (a/a+c)   =  33/41 = 0.8 
(true positive) 
            80% 
Specificity (d/b+d)   =  19/27 = 0.7 
(true negative) 
            70% 
 Positive predictive value  (a/a+b) = 33/41 = 0.8 
           80% 
 Negative predictive value  (d/c+d) = 19/27 = 0.7 
           70%  
 Percentage of false positive b/b+d = 8/27 = 0.3 
           30%  
 Percentage of false negative c/a+c = 8/41 = 0.2 
           20% 
TABLE - 26 
AGE DISTRIBUTION WITH PREINVASIVE AND INVASIVE LESIONS 
(HISTOLOGY) 
 
Age MD MOD SD Ca Total 
20-30 7 2 - - 9 
31-40 8 2 4 3 17 
41-50 6 - 5 4 15 
>50 - - - - - 
Total     41 
 
 The number of cases diagnosed histology as preinvasive and invasive 
lesions were more in the age group of 31 - 40 yrs (17%) followed by 41 - 50 yrs 
(15%) 
TABLE - 27 
COLPOSCOPY RESULTS 
 
Grading n=68 Percentage 
Normal 27 40 
I 15 22 
II 19 28 
III 7 10 
 
DISCUSSION 
 
 The concept of screening has been defined as the search for unrecognized 
disease or defect by means of rapidly applied tests, examination or other 
procedures in apparently healthy individual. 
 The present study was conducted to evaluate the efficiency of liquid based 
cytology diagnostic modality in the diagnosis of cervical cancer and to 
quantitative its correlation with the histopathology. 
 In this study 300 patients were randomly selected and both conventional 
pap and liquid based cytology are applied to the same women and compared in a 
within subject analysis. 
 The advantage is that many characteristics are equivalent for both tests 
(including patient attributes, timing in the menstrual cycle, clinician factors). 
within subject analysis is common in diagnostic accuracy studies for cervical 
cancer screening because it is relatively simple to collect two samples during a 
pelvic examination. 
• Of the total cases examined 50.3% cases were in the age group of 31 - 40 
yrs. 
• 61% of the cases screened were multiparous women. 
• 38% of the cases were illiterate and 39.3% of cases had their secondary 
schooling and above. 
• 45% of the cases screened were from socioeconomic class V and 97% of 
cases were menstruating. 
• 99% of cases in this study followed other than barrier contraception, a  
main risk factor for cancer cervix in low socioeconomic group. 
• 16% of couples had taken treatment for STD. 
• The main complaint among the screened population was white discharge 
followed by urinary tract infection and lower abdominal pain. 
Diagnostic accuracy 
 In this study LBC method of specimen preparation led to the cytological 
diagnosis of significantly more cervical abnormalities than the conventional 
method. (52 Vs 36). 
 Depending on the prevalence of the disease in a population there may be 
more cases of higher grade abnormalities such as high grade squamous 
intraepitralial lesion (HSIL) and cancer which are the most important outcomes for 
a test to detect. 
 LBC technique has  detected more high grade lesions then that of pap (20 
Vs 6%). 
In one of the first studies done by Wilbur and associates a total of 3218 
patients had a single cytologic sample that was split into matched pairs. The 
inferred false -ve rate was 15% for cp and 4% for LBC. In this study false negative 
rate for CP is 61.6% and for LBC 2%. 
 The study by Lee there was 14% difference between the Cp & LBC. 
 Robert's and associates did split sample paired Cp & LBC in 35,560 
patients and found LBC showed those severe abnormalities in 1194 cases 
compared with the Cp. In this study cases with severe abnormalities LBC 6.7% CP 
- 2%. 
 Bernstein et al., found that the overall sample adequacy improved with the 
LBC but the incidence and diagnosis of ASCUS was not reduced. The sensitivity 
of screening test was also found to be increased. The sensitivity of LBC in this 
study is 97%. 
Infection 
 The detection of infections was very much increased in the LBC technique. 
Out of 40 Trichomonas  infection detected  26 cases were detected with LBC. Out 
of 20 cases with candida LBC diagnosed 11 cases. 
Specimen adequacy 
 Specimen adequacy also was improved significantly with the LBC method. 
The reduction in the number of slides compromised by obscuring  amounts of 
blood, mucus, inflammation and air drying artifact may reduce significantly the 
need to repeat the screening procedure. 
 An increase is specimen adequacy is due to the fact that the cervical cells 
that are removed with brush are rinsed in a "direct to vial" method. All the cells 
are collected in the preservative solution immediately and also reduces the 
likelihood that a patient cell sample will be damaged by air, clumping etc and also 
the sample is subjected to a device where it is spun and the obscurring materials 
were absorbed by the filter card. 
 In case of pap the whole sample is not smeared on the slide and if there is a 
delay in fixation sample will be damaged by air drying artifact, clumping etc. 
 A 1994 study published in American Journal of clinical pathology found 
that upto 80% of a sample taken from a patient using the conventional pap smear 
techniques is not smeared on the slide but remains on the collection device. 
Collection device 
 As the pap smear has been taken with a wooden spatula it is thought to 
reduce the sensitivity because of absorptive properties of wood. 
 In case of LBC brush is used which has showed a significant difference in 
the quality of the sample prepared. 
 There is evidence that the device used to collect cervical cell specimens 
plays a significant role in determining the sensitivity and specificity of the test 
(Austin and Ramsey 1998). 
 According to ASCCP guideline the increased sensitivity of the brush make 
it the preferred instrument for cervical sampling. 
 As spatula is used for pap sometimes scarring of the cervix, mucosal tears 
may happen and the blood is also collected on the slide make it different to read 
the slide. 
 The transformation zone as the age advances goes deeper into cervical 
canal for which brush will be a better option than that of spatula. 
Cost effectiveness 
 Even though cost estimation per women in LBC is increased, the number of 
inflammatory smears detected in pap has been shown to be normal in LBC (66.7% 
Vs 5.3%). 
 This will reduce the treatment cost as well as the repeat smear cost after 
treatment for those with inflammatory smears. 
 Reduction in pressure on a skilled workforce as it is clearer to read samples 
and the workload and payment to the staff will be reduced. 
The economic evidence of trial studies suggest that LBC screening every 3 
years or longer after a normal test may be cost effective relative to pap smear 
screening every year. 
 As the number of prior normal LBC test increases the cost per life year 
saved will be increased substantially. 
 Table 22 - comparative analysis of various studies have shown the 
increased sensitivity of LBC over that of pap smear. 
 Vaginal cytology reports previous years show the inflammatory rate 
remains equal because of the direct smearing of the slide with sample so that 
blood, mucus, debris are transferred to the slide. Also cell over lapping and 
distortion due to air drying can complicate the evaluation of cell changes. 
 The smaller screening area on the microscope slide and the clarity of LBC 
specimen increase the ease of screening. 
Results of LBC with that of histology 
  Detection of invasive or metastatic cancer is considered to be the gold 
standard a longitudinal study is best. Because of time, expense and difficulty 
involved with a longitudinal study an acceptable surrogate is histology. A clinical 
diagnosis is based on biopsy conformation. 
 The evaluation of women with negative test result is considered to be 
invasive and costly. As a result the use of colposcopy and the histological 
followup is limited to women with positive diagnosis identified by LBC and pap 
tests. 
 Out of 32 cases in LBC 19 cases where confirmed by histology as mild 
dysplasia; 12 cases as chronic cervicitis. 1 case in LBC was diagnosed as such as 
moderate dysplasia. Out of 6 cases 6 cases were diagnosed as invasive cancer. 
HSIL - out of 14 cases 1 went as mild dysplasia (LSIL) and 1 as invasive 
cancer. 
 Duration of marriage had a strong impact on development of cancer cervix. 
The patients with severe dysplasia and cancer cervix has a longer duration of 
marriage (> 20  yrs) Those patients with normal cytology had a lesser duration of 
marriage < 10. yrs. 
 
Treated for STD 
 Out of 48 coupes treated for STD 13 women had cervical changes in LBC. 
This shows the impact of STD in the etiology of cancer cervix. 
Age distribution 
 The maximum indicence of cancer cervix is in the age group of 35 - 64 
(ASRW 57.4) (MMTR Chennai, 2002). 
In this study patients with HSIL were in the age group of 31 - 40 This 
shows the incidence of cancer cervix has shifted to a lower age group. 
 The average age of first coitus was 17 yrs for cases with cervical changes. 
This shows that early age of sexual activity has an strong impact. 
Out of 2 post menopausal women with cervical changes one was diagnosed 
as severe dysplasia and another as mild dysplasia. 
53% of cases with cervical changes belong to socioeconomic class V. 
Extra / Premarital contact (women) 
 Out  of 8 cases 1 case was diagnosed mild dysplasia 4 cases were normal 2 
as severe dysplasia and 1 case as moderate dysplasia by histology. 
Result of Colposcopy Vs histology 
 Out of 68 cases of colposcopy done 27 cases were normal of which 3 cases 
were diagnosed LSIL and 5 case as HSIL 
 Grade I (insignificant, not suspicious) - Total 15 cases 7 cases were LSIL. 
 Grade II (Significant suspicious) - Total 19 cases 11 cases were diagnosed 
as LSIL and 4 cases as HSIL and 4 cases as invasive cancer. 
 Grade III (highly significant, highly, suspicious) - Total 7 cases 4 cases as 
HSIL and 3 cases as cancer. 
Distribution of colposcopic findings 
 1. Normal study    - 27 
 2. Abnormal 
  Acetowhite epithelium  - 12 
  Punctation   - 6 
  Mosaic    - 3 
  Leucoplakia   - 2 
  Atypical vessels   - 3 
 3. Frank invasive carcinoma  -  7 
 4. Erosion     - 8 
 
The diagnostic accuracy of CIN detected by colposcopy given by various 
authors. 
SCOH 1967 90% 
S.S.Iyar 1979 87% 
Bandi et al 1985 89% 
Usha Surayi 1986 92.6% 
Present study  80% 
 
The frequency of cancer detection by colposcopy by various authors and 
present series. 
 Zurich  - 2.8% 
 Limburg - 9.8% 
 Brentran - 11.3% 
Burgart - 10.08% 
Present series - 10.3% 
SUMMARY 
 Out of 300 patients screened for cancer cervix with conventional pap and 
Liquid based cytology in the same patient 
 a. LBC detection rate of cervical abnormalities and HSIL was more 
than that of CP. 
 b. False -ve rate of LBC only 2% 
 c. Sensitivity 97% and false positive rate is 44% 
 d. The sensitivity is as equal to gold standard method. 
 e. Infection detection rate increased with LBC 
 f. Specimen adequacy improved with LBC substantially 
 g. The collection sample  device brush found superior to wooden 
Ayre's spatula both not in injuring tissues and specimen collection.  
 h. The adverse impact on a women's quality of life caused by 
unnecessary repeat smears and possible investigations would reduce 
the cost with LBC. 
 i. The economic evidence suggests that LBC screening every 3 yrs of 
longer may be cost effective. 
 j. LBC reduced the pressure on a skilled workforce. 
 Colposcopy has become as integral part of modern gynaecologic practice. 
the sensitivity and specificity is high. However its main indication remains 
examination of women with abnormal smears and a trained personnel is required 
as false positive results may end up in unnecessary treatment modalities and only 
ecto cervix lesions can be detected. 
 As cytology is ideal for mass screening, specimen can be obtained by non 
medical professional, detects lesion both in ecto and endo cervix and cost effective 
LBC is a better alternative and colposcopy directed biopsy can be done in patients 
with abnormal smears. 
Scope for future study 
 LBC have been developed to improve the detection of cervical cancer and 
its precursors and reduce the rate of false negative results from conventional 
cervical smear tests. In several countries liquid based cytology is replacing 
conventional smear tests. A thorough economical evaluation is needed for this new 
technique (LBC) to be implemented in our country as a mass screening and also 
human papilloma virus testing as complementarily to conventional smear testing 
should be further evaluated in clinical research. 
 As thin prep and surepath method of thin layer preparation is automatic and 
costlier an alternative and cheaper method of cytocentrifuge is suitable for our 
country. The cost effectiveness and accuracy can be done in a large scale trial. 
 
CONCLUSION 
 WHO Press Release, 11 October 2001, points out that. 
 We should aim to divert out resources for screening and treating the high 
risks group of women. The effort once or twice in their lifetime will reduce the 
incidence of cervical cancer by 50%. 
 In this scenario mass screening with LBC  which has a high detection rate 
for HSIL and colposcope for abnormal smears offers a potent method of rapid 
assessment of any dysplasia possibly present. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF ABBREVIATIONS 
CIN  - Cervical Intraepithelial Neoplasia 
CIS  - Carcinoma in situ 
WHO  - World Health Organization 
ICMR  - Indian Council of Medical Research 
HPV  - Human Papilloma Virus 
HSV  - Herpes Simplex Virus 
OCP  - Oral contraceptive pill 
HLA  - Human Leukocyte antigen 
STD  - Sexually transmitted Disease 
DNA  - Deoxy ribo nucleic acid 
IARC  - International Agency for research in cancer 
MHC  - Major  Histocompatabality complex 
HIV  - Human immunodeficiency virus 
LBC  - Liquid based cytology 
PAP  - Papanicoloau 
LSIL  - Low grade squamous intraepithelial lesion 
HSIL  - High grade squamous intraepithelial lesion 
SCJ  - Squamous columnar junction 
NICE  - National Institute for clinical excellence  
CP  - Conventional Pap 
-ve  - Negative 
+ve  - Positive 
ASCUS - Atypical squamous cells of undetermined  
significance 
HCII  - Hybrid culture II assays 
LAMS  - Latin American Screening  
 ASCCP - American society for colposcopy and cervical pathology 
PROFORMA 
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Sl. No. 
 
OP No. 
 
SE Status 
 
Residence 
 
Menstrual History 
 
Married    Yes / No 
 
Age at Marriage 
 
Sexual History  
 
Husband : Premarital 
   Extramarital 
 
Patient : Premarital 
   Extramarital 
 
Obstetric History 
 
Contraceptive methods 
 
Presenting Complaint 
 
a) White discharge duration 
b) Post coital bleeding 
c) LAP 
d) Backache  
e) Post Menopausal bleeding 
 
Past Medical History 
 
a) Treated for STD 
 
General Examination 
 
Per Abdomen 
 
Per  Speculum 
 
Per Vagimum 
 
Per Rectum   mucosa free Yes / No 
 
Diagnosis  
 
PAP 
 
LBC 
 
COLPOSCOPY 
 
 
 
 
 
 
 
 
 
 Odell's Diagram 
 
Histopathology report 
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